Glucocorticoid-related bone changes from endogenous or exoge... : Current Opinion in
Endocrinology, Diabetes and Obesity Glucocorticoid-related bone changes from endogenous …

Osteoporosis is a common consequence of long-term oral glucocorticoid therapy and the
resulting fractures cause significant morbidity. Bone loss occurs rapidly after initiation of …

We studied the association between bisphosphonate use and risk of atrial fibrillation or
flutter and the effect of confounders such as heart and lung disease in a nationwide …

Glucocorticoid (GC)-induced osteoporosis is the main cause of secondary osteoporosis.
Fractures, which are often asymptomatic, can occur in as many as 50% of patients receiving …

Introduction: Pathological fractures are frequent skeletal-related events among lung cancer
patients, which result in high morbidity and decreased overall survival and make operative …

Osteoporosis is a major health problem, affecting more than 200 million people worldwide
(Kanis, JA, WHO Scientific Group: Assessment of Osteoporosis at the Primary Health Care …

Glucocorticoid-induced osteoporosis is a leading cause of secondary osteoporosis, one of
the more devastating consequences of glucocorticoid therapy. Bone mineral density …

We studied the fracture risk associated with use of methotrexate, azathioprine, and
cyclosporine. The study was designed as a case-control study. All patients with a fracture …

Utilization of DXA Bone Mineral Densitometry in Ontario - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Introduction Chronic obstructive pulmonary disease (COPD) is characterised by persistent
airflow obstruction and respiratory symptoms. While short course systemic GCs are …